Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories diluted Earnings Per Common Share ($/share) ($)
Postgres DB financial_values + XBRL
Latest, FY2025
3.72
Period ended Dec 31, 2025
Change on a year earlier
-51.3%
7.64 in FY2024
History
19 years
Since FY2007
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diluted Earnings Per Common Share ($/share) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.72 | -51.3% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 7.64 | +134.4% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 3.26 | -16.6% | Form 10-K (filed 2024-02-16) ↗ |
| FY2022 | Dec 31, 2022 | 3.91 | -0.8% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 3.94 | +57.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 2.50 | +21.4% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 2.06 | +54.9% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 1.33 | +392.6% | Form 10-K (filed 2019-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 0.27 | -71.3% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 0.94 | -67.8% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 2.92 | +96.0% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 1.49 | -8.0% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 1.62 | -56.5% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 3.72 | +23.6% | Form 10-K (filed 2013-02-15) ↗ |
| FY2011 | Dec 31, 2011 | 3.01 | +1.7% | Form 10-K (filed 2012-02-21) ↗ |
| FY2010 | Dec 31, 2010 | 2.96 | -19.8% | Form 10-K (filed 2011-02-18) ↗ |
| FY2009 | Dec 31, 2009 | 3.69 | +18.3% | Form 10-K (filed 2010-02-19) ↗ |
| FY2008 | Dec 31, 2008 | 3.12 | +35.1% | Form 10-K (filed 2010-02-19) ↗ |
| FY2007 | Dec 31, 2007 | 2.31 | – | Form 10-K (filed 2010-02-19) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Diluted Earnings Per Common Share ($/share) ($), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-eps-dil
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.